Vandetanib (Caprelsa, Sanofi), a thyroid cancer medication, is an oral tyrosine kinase inhibitor that targets cell receptors involved in RET, VEGFR and EGFR signaling. The FDA has removed the Risk ...

In recent years a growing number of foundations have fastidiously articulated new program goals to support people of color, people who are LBGTQ, people with low incomes, and others facing barriers to ...